Andreas Meyer-Lindenberg
Prof Andreas Meyer-Lindenberg, MD is an expert in Psychiatry at Central Institute of Mental Health (Germany). As of October 2026, ScienceLeadR ranks Andreas Meyer-Lindenberg in the top 1% of experts worldwide for Schizophrenia and Schizophrenia Spectrum and Other Psychotic Disorders. Andreas Meyer-Lindenberg has authored 823 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 2,549 (community average: 125). How the SLR is computed.
LeadR Profile
Psychiatry
Subspecialties: Neurology - Psychology - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 823
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A study design for modulating two components of the risk architecture of chronic pain: adverse life events and pain catastrophising. PMID 42827980 — research design, chronic pain, emotions, pain, brain, signs and symptoms, brain stem, therapeutics, affective symptoms, negotiating | Front Psychol | 2026 | 0 |
| Capturing affective states in everyday life - Comparing psychometric properties of two affect measures. PMID 42828125 — psychometrics | Neurosci Appl | 2026 | 0 |
| Neuropsychobiological transdiagnostic risk mechanisms for aggression in mental disorders across the life span. PMID 42816837 — mental disorders, aggression | BMC Psychiatry | 2026 | 1 |
| A genus-labeled dataset of individual trees outside forests in Baden-Württemberg, Germany. PMID 42816537 — imagery, psychotherapy, crowns, forests | Sci Data | 2026 | 1 |
| Rethinking biomarkers in psychiatry: from etiological uncertainty to actionable prediction. PMID 42742577 — uncertainty, biomarkers, psychiatry | World Psychiatry Top journal | 2026 | 0 |
Clinical Studies 9
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| FEEL GOOD A Multicenter Trial of a Mindfulness Based Group Therapy in Young Adults With Early Psychosis NCT07645443 — emotions, anger, drug therapy, signs and symptoms, social work, mindfulness, schizophrenia, occupational therapy, work, ecological momentary assessment, schizophrenia, paranoid, shame, therapeutics, psychotic disorders, emotional regulation | N/A | Recruiting | 2026 |
| A Study Evaluating the Efficacy of Xanomeline Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia NCT07084831 — quality of life, neurobehavioral manifestations, hallucinations, brain, cognitive dysfunction, signs and symptoms, schizophrenia, cognition disorders, work, therapeutics, memory, psychotic disorders, cognition, speech, delusions | Phase 3 | Not yet recruiting | 2027 |
LeadR Networks
Main global connection map